Next Article in Journal
Should Noncurative Resection of the Primary Tumour Be Performed in Patients with Stage iv Colorectal Cancer? A Systematic Review and Meta-Analysis
Previous Article in Journal
Patterns of Practice in the Prescription of Palliative Radiotherapy for the Treatment of Bone Metastases at the Rapid Response Radiotherapy Program between 2005 and 2012
 
 
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Recurrent Nasopharyngeal Carcinoma: A Clinical Dilemma and Challenge

1
Department of Radiation Oncology, First People’s Hospital of Foshan Affiliated to Sun Yat-Sen University, Foshan, China
2
Department of Pathophysiology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, China
3
Department of Otolaryngology, First People’s Hospital of Foshan Affiliated to Sun Yat-Sen University, Foshan, China
4
Department of Radiation Oncology, Cancer Center, Sun Yat-Sen University, Guangzhou, China
5
Department of Radiology, Cancer Center, Sun Yat-Sen University, Guangzhou, China
*
Authors to whom correspondence should be addressed.
Curr. Oncol. 2013, 20(5), 406-419; https://doi.org/10.3747/co.20.1456
Submission received: 10 July 2013 / Revised: 8 August 2013 / Accepted: 11 September 2013 / Published: 1 October 2013

Abstract

Recurrent nasopharyngeal carcinoma, which represents a small proportion of head-and-neck cancers, has a unique set of patho-clinical characteristics. The management of recurrent nasopharyngeal carcinoma remains a challenging clinical problem. Traditional treatments offer limited local control and survival benefits; more seriously, they frequently induce severe late complications. Recently, novel treatment techniques and strategies—including precision radiotherapy, endoscopic surgery or transoral robotic resection, third-generation chemotherapy regimens, and targeted therapies and immunotherapy—have provided new hope for patients with recurrent nasopharyngeal carcinoma. Some of these patients can potentially be cured with modern treatments. However, a lack of adequate evidence makes it difficult for clinicians to apply these powerful techniques and strategies. Individualized management guidelines, full evaluation of quality of life in these patients, and a further understanding of the mechanisms underlying recurrence are future directions for research into recurrent nasopharyngeal carcinoma.
Keywords: nasopharyngeal carcinoma; recurrence; surgery; radiotherapy; chemotherapy; biotherapy nasopharyngeal carcinoma; recurrence; surgery; radiotherapy; chemotherapy; biotherapy

Share and Cite

MDPI and ACS Style

Xu, T.; Tang, J.; Gu, M.; Liu, L.; Wei, W.; Yang, H. Recurrent Nasopharyngeal Carcinoma: A Clinical Dilemma and Challenge. Curr. Oncol. 2013, 20, 406-419. https://doi.org/10.3747/co.20.1456

AMA Style

Xu T, Tang J, Gu M, Liu L, Wei W, Yang H. Recurrent Nasopharyngeal Carcinoma: A Clinical Dilemma and Challenge. Current Oncology. 2013; 20(5):406-419. https://doi.org/10.3747/co.20.1456

Chicago/Turabian Style

Xu, Tao, J. Tang, M. Gu, L. Liu, W. Wei, and H. Yang. 2013. "Recurrent Nasopharyngeal Carcinoma: A Clinical Dilemma and Challenge" Current Oncology 20, no. 5: 406-419. https://doi.org/10.3747/co.20.1456

APA Style

Xu, T., Tang, J., Gu, M., Liu, L., Wei, W., & Yang, H. (2013). Recurrent Nasopharyngeal Carcinoma: A Clinical Dilemma and Challenge. Current Oncology, 20(5), 406-419. https://doi.org/10.3747/co.20.1456

Article Metrics

Back to TopTop